Quant Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 21-02-2025
NAV ₹14.06(R) -0.9% ₹14.43(D) -0.89%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 1.74% -% -% -% -%
Direct 3.43% -% -% -% -%
Nifty Pharma TRI 8.49% 16.98% 20.4% 13.51% 6.47%
SIP (XIRR) Regular -11.88% -% -% -% -%
Direct -10.32% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Pharma Fund
Fund Name Rank Rating
Sbi Healthcare Opportunities Fund -
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -
Nippon India Pharma Fund -
Mirae Asset Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -

NAV Date: 21-02-2025

Scheme Name NAV Rupee Change Percent Change
quant Healthcare Fund - Growth Option - Regular Plan 14.06
-0.1300
-0.9000%
quant Healthcare Fund - IDCW Option - Regular Plan 14.06
-0.1300
-0.8900%
quant Healthcare Fund - Growth Option - Direct Plan 14.43
-0.1300
-0.8900%
quant Healthcare Fund - IDCW Option - Direct Plan 14.43
-0.1300
-0.8900%

Review Date: 21-02-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It signifies the growth in the investment's value over a specific period, presented either as a percentage or a monetary figure. Our analysis focused on four return parameters of this fund. The return parameters have been categorized into three performance groups: the top 25%, those below the top 25% but above average, and those below average. Now, let's take a look at how each parameter has performed.
    1. Top 25%: The fund does not have any return parameter in the top 25% in the category.
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Four return parameters of the fund are below average in the category, which are listed below:
      • 1Y Return %
      • 1M Return %
      • 3M Return %
      • 6M Return %
  2. Risk: It is defined as the prospect of not attaining expected yields or enduring financial setbacks due to numerous causes. For quant Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: quant Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: quant Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: quant Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated zero risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -7.62 -6.64
-6.97
-9.04 | -5.72 11 | 13 Average
3M Return % -9.68 -6.02
-6.79
-9.68 | -4.84 13 | 13 Poor
6M Return % -17.69 -9.49
-6.24
-17.69 | -0.25 13 | 13 Poor
1Y Return % 1.74 8.49
11.55
1.74 | 21.28 13 | 13 Poor
1Y SIP Return % -11.88
1.08
-11.88 | 13.28 13 | 13 Poor
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -7.49 -6.64 -6.87 -8.93 | -5.64 10 | 13
3M Return % -9.30 -6.02 -6.48 -9.30 | -4.55 13 | 13
6M Return % -16.99 -9.49 -5.62 -16.99 | 0.61 13 | 13
1Y Return % 3.43 8.49 13.01 3.43 | 22.79 13 | 13
1Y SIP Return % -10.32 2.46 -10.32 | 14.73 13 | 13
Return data last Updated On : Feb. 21, 2025.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Jan. 31, 2025
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -0.90 ₹ 9,910.00 -0.89 ₹ 9,911.00
1W 0.88 ₹ 10,088.00 0.92 ₹ 10,092.00
1M -7.62 ₹ 9,238.00 -7.49 ₹ 9,251.00
3M -9.68 ₹ 9,032.00 -9.30 ₹ 9,070.00
6M -17.69 ₹ 8,231.00 -16.99 ₹ 8,301.00
1Y 1.74 ₹ 10,174.00 3.43 ₹ 10,343.00
3Y ₹ ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -11.88 ₹ 11,209.21 -10.32 ₹ 11,314.70
3Y ₹ 36000 ₹ ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Quant Healthcare Fund NAV Regular Growth Quant Healthcare Fund NAV Direct Growth
21-02-2025 14.0567 14.4323
20-02-2025 14.1837 14.562
19-02-2025 14.0209 14.3942
18-02-2025 13.8454 14.2134
17-02-2025 14.0417 14.4143
14-02-2025 13.9336 14.3013
13-02-2025 14.3716 14.7502
12-02-2025 14.2275 14.6016
11-02-2025 14.3329 14.7091
10-02-2025 14.8294 15.2179
07-02-2025 15.1863 15.5821
06-02-2025 15.2712 15.6685
05-02-2025 15.1609 15.5546
04-02-2025 15.0772 15.4681
03-02-2025 14.8344 15.2183
31-01-2025 14.9595 15.3446
30-01-2025 14.8865 15.2689
29-01-2025 14.7604 15.1389
28-01-2025 14.3833 14.7514
27-01-2025 14.7022 15.0778
24-01-2025 14.9117 15.2906
23-01-2025 15.2284 15.6146
22-01-2025 15.045 15.4258
21-01-2025 15.2162 15.6007

Fund Launch Date: 17/Jul/2023
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Benchmark: BSE Healthcare TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.